- Home
- WEST vs SVRA Comparison
WEST vs SVRA Comparison
Compare WEST & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WEST
- SVRA
- Stock Information
- Founded
- WEST 2009
- SVRA 2007
- Country
- WEST United States
- SVRA United States
- Employees
- WEST N/A
- SVRA N/A
- Industry
- WEST Beverages (Production/Distribution)
- SVRA Biotechnology: Pharmaceutical Preparations
- Sector
- WEST Consumer Staples
- SVRA Health Care
- Exchange
- WEST Nasdaq
- SVRA Nasdaq
- Market Cap
- WEST 640.7M
- SVRA 528.3M
- IPO Year
- WEST N/A
- SVRA N/A
- Fundamental
- Price
- WEST $6.26
- SVRA $2.36
- Analyst Decision
- WEST Strong Buy
- SVRA Buy
- Analyst Count
- WEST 5
- SVRA 5
- Target Price
- WEST $10.60
- SVRA $5.60
- AVG Volume (30 Days)
- WEST 273.1K
- SVRA 1.3M
- Earning Date
- WEST 08-07-2025
- SVRA 08-11-2025
- Dividend Yield
- WEST N/A
- SVRA N/A
- EPS Growth
- WEST N/A
- SVRA N/A
- EPS
- WEST N/A
- SVRA N/A
- Revenue
- WEST $872,022,000.00
- SVRA N/A
- Revenue This Year
- WEST $22.72
- SVRA N/A
- Revenue Next Year
- WEST $14.75
- SVRA N/A
- P/E Ratio
- WEST N/A
- SVRA N/A
- Revenue Growth
- WEST 2.38
- SVRA N/A
- 52 Week Low
- WEST $5.28
- SVRA $1.89
- 52 Week High
- WEST $10.17
- SVRA $5.11
- Technical
- Relative Strength Index (RSI)
- WEST 47.75
- SVRA 51.18
- Support Level
- WEST $5.65
- SVRA $1.98
- Resistance Level
- WEST $6.54
- SVRA $2.41
- Average True Range (ATR)
- WEST 0.28
- SVRA 0.16
- MACD
- WEST 0.04
- SVRA 0.04
- Stochastic Oscillator
- WEST 61.81
- SVRA 83.72
About WEST Westrock Coffee Company
Westrock Coffee Co is an integrated coffee, tea, flavors, extracts, and ingredients solutions provider in the U.S, providing coffee sourcing, supply chain management, product development, roasting, packaging, and distribution services to retail, foodservice and restaurant, convenience store and travel center, non-commercial account, CPG, and hospitality industries around the world. The company's segment includes Beverage Solutions and Sustainable Sourcing and Traceability. It generates maximum revenue from the Beverage Solutions segment.
About SVRA Savara Inc.
Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.